The secondaries market anticipates 2024 will be a record year for volume, with first-half figures coming in at between $68bn and $72bn.
4 min read · 30 December 2024
eQ PE SF V, which surpassed its target, is the smallest in the manager’s secondaries series.
2 min read · 23 December 2024
There’s a growing set of more than 28,000 buyout companies with diminished IPO and M&A exit avenues, according to Kline Hill Partners’ Mike Bego.
4 min read · 23 December 2024
The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.
2 min read · 20 December 2024
The firm has temporarily delayed capital raising for GP Equity Solutions and is instead focusing on dealmaking, Secondaries Investor has learned.
2 min read · 19 December 2024
Evergreen structures, sophisticated capital pacing models and the use of fund finance have all helped make private markets more accessible for an asset class that remains fundamentally illiquid.
7 min read · 17 December 2024
While continuation funds are increasingly common liquidity solutions, not all of them are delivering the appropriate returns, according to Cari Lodge, head of secondaries at Commonfund.
2 min read · 16 December 2024
The fund will be managed by Ant Solutions Partners, a newly formed spinoff of Ant Capital’s Solution Investment Group.
2 min read · 13 December 2024
Our latest episode of Second Thoughts involved a basket of onions, a permanent marker and two well-respected professionals from Kirkland & Ellis and CVC Secondary Partners.
2 min read · 12 December 2024
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
2 min read · 11 December 2024